Gender-Related Differences in Disease Activity and Clinical Features in Patients with Peripheral Psoriatic Arthritis: A Multi-Center Study.
This study sought to compare disease activity, clinical features, and patient-reported outcomes...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 41 - 60 of 410 results for 'psoriatic disease'
Health resource utilization and associated healthcare costs of biologic disease modifying antirheumatic drugs in German patients with psoriatic arthritis.
To investigate healthcare costs associated with biologic disease-modifying antirheumatic drugs...
Read More
Impact of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
To compare disease characteristics, quality of life (QOL), and work productivity of patients with...
Read More
Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index.
To assess the interchangeability of the Health Assessment Questionnaire-Disability Index (HAQ-DI)...
Read More
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study.
The aim of this study was to evaluate the impact of comorbidities on disease activity,...
Read MoreMismatch between the impact of disease perceived by patients and the state of clinical remission assessed by physicians in psoriatic arthritis.
Both the evaluation of disease activity and the assessment of the impact of the disease on patients’ lives are subjects of intense research at present in psoriatic arthritis (PsA). We aimed to test the degree of...
Read More
Comparing Perceptions of Psoriatic Arthritis Disease Activity
While guidelines for psoriatic arthritis recommend a treatment target of remission or low disease...
Read More
Liver Disease & Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis
Relatively little is known about the risk for incident liver disease in patients with psoriasis...
Read More
Metabolic Dysfunction-Associated Liver Disease in Psoriasis
The following is a summary of “Identification of risk factors associated with metabolic...
Read MoreAdvertisement
Impact of Weather Variation on Disease Activity & Outcomes in PsA
The following is a summary of “A Real-World Analysis of Weather Variation on Disease Activity and...
Read MoreSuperior effect of adalimumab versus secukinumab on ultrasound-confirmed synovitis in psoriatic arthritis: comprehensive evidence from musculoskeletal ultrasound and clinical assessments.
Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disorder affecting 30% of psoriatic patients. Effective treatment, especially with biologics like IL-17 and TNF inhibitors, is vital for improving patient...
Read MorePatient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness Survey.
Psoriatic arthritis (PsA) is a chronic, autoimmune form of arthritis that is associated with a substantial humanistic and economic burden. Potential differences in patient-reported outcomes (PROs) and economic outcomes among...
Read More
Loneliness Highly Prevalent in Inflammatory Arthritis & Associated With Disease Activity
The following is a summary of “Associations between loneliness, disease activity, and disease...
Read More
Disease Activity Stable with TNFi Tapering; ADAb and Drug Levels Not Predictive
The following is a summary of “Exploring TNFi drug-levels and anti-drug antibodies during tapering...
Read More
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
PsA and AD can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment.
Read More
Towards Prevention of Psoriatic Arthritis in Patients With Psoriasis
Risk factors for patients with psoriasis developing psoriatic arthritis, and potential pharmacological and non-pharmacological interventions.
Read More
Exploring Current and Future Biologic Therapies for Psoriatic Arthritis
What is the current state of biological therapies for psoriatic arthritis, and what does the future of biological therapy for psoriatic arthritis hold?
Read More
CME/CE: PROMs as Important as Disease Activity Indexes for Assessing PsA
This course discusses a study that elucidated the value of patient-reported outcome measures in...
Read MoreAddressing “Unacceptable” Disease Activity in Nearly 60% of Patients With PsA
The majority of patients living with PsA reported experiencing “unacceptable” disease activity, causing potentially serious psychosocial harm, according to survey results collected by researchers with the National Psoriasis...
Read More
Comparing BASDAI & ASDAS in Axial Psoriatic Arthritis
The study concluded that BASDAI and ASDAS are effective tools for evaluating axial disease activity in PsA
Read More